Market Place
Sourcing Support
Biora, with spin on Xeljanz nearing the clinic, posts data
11 Jul 2022 //
FIERCEPHARMA
Progenity Announces Successful Transfer of Liquid Biopsy Technologies
05 May 2022 //
GLOBENEWSWIRE
Progenity to Report First Quarter Financial Results
03 May 2022 //
GLOBENEWSWIRE
Progenity Appoints Paul Shabram to Lead Technical Operations of the Company’s
25 Apr 2022 //
GLOBENEWSWIRE
Progenity to Become Biora Therapeutics as it Completes Transformation
12 Apr 2022 //
GLOBENEWSWIRE
Progenity Announces Two Poster Presentations at Controlled Release Society 2022
06 Apr 2022 //
GLOBENEWSWIRE
Progenity Reports Fourth Quarter and Full Year 2021 Financial Results
28 Mar 2022 //
GLOBENEWSWIRE
Progenity to Report Q4 and FY 2021 Financial Results
16 Mar 2022 //
GLOBENEWSWIRE
Progenity Progresses its Drug Delivery System Device Performance Studies
10 Mar 2022 //
GLOBENEWSWIRE
Progenity Announces Acceptance of Three Abstracts at Digestive Disease Week 2022
28 Feb 2022 //
GLOBENEWSWIRE
Progenity Shares 2 Poster Presentations on Treatment of GI Disorders at ECCO’22
22 Feb 2022 //
GLOBENEWSWIRE
Progenity Strengthens IP for Single-Molecule Detection Technology
25 Jan 2022 //
GLOBENEWSWIRE
Progenity Announces Oral Presentation on Treatment of Gastrointestinal Disorders
11 Jan 2022 //
GLOBENEWSWIRE
Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab
20 Dec 2021 //
GLOBENEWSWIRE
Progenity to Participate in the Piper Sandler 33rd Annual VHC
15 Nov 2021 //
GLOBENEWSWIRE
Progenity Announces Several Patents Granted by USPTO, Strengthening
13 Oct 2021 //
GLOBENEWSWIRE
Progenity soars 40% after granted patent for device
11 Oct 2021 //
SEEKING ALPHA
Progenity Announces Closing of $20 Million Registered Direct Offering
06 Oct 2021 //
GLOBENEWSWIRE
Progenity Announces $20 Million Registered Direct Offering of Common Stock
04 Oct 2021 //
GLOBENEWSWIRE
Progenity Announces $20 Million Registered Direct Offering of Common Stock
04 Oct 2021 //
GLOBENEWSWIRE
Progenity Announces Patent Granted by USPTO for Preeclampsia Rule-Out Test
14 Sep 2021 //
GLOBENEWSWIRE
Progenity soars 16% amid getting US patent for pregnancy complication test
14 Sep 2021 //
SEEKINGALPHA
Progenity CEO Harry Stylli steps down, names Mr. d`Esparbes as interim CEO
02 Sep 2021 //
SEEKING ALPHA
Progenity Announces Closing of $40 Million Underwritten Public Offering
24 Aug 2021 //
GLOBENEWSWIRE
Progenity secures $40M via equity raise
20 Aug 2021 //
YAHOO
Progenity Announces Pricing of $40M Public Offering of Common Stock and Warrants
19 Aug 2021 //
GLOBENEWSWIRE
Progenity Announces Appointment of Surbhi Sarna to its Board of Directors
30 Jun 2021 //
GLOBENEWSWIRE
Progenity Establishes Inflammatory Bowel Disease Clinical Advisory Board
17 Jun 2021 //
GLOBENEWSWIRE
Progenity to Participate in the Raymond James Human Health Innovation Conference
15 Jun 2021 //
GLOBENEWSWIRE
Progenity Provides Results from Key Study for Its Targeted Therapeutics Program
26 May 2021 //
GLOBENEWSWIRE
Progenity Announces Poster Presentations at Digestive Disease Week 2021
24 May 2021 //
GLOBENEWSWIRE
Progenity Provides Preliminary Results for its Targeted Therapeutics Program
12 May 2021 //
GLOBENEWSWIRE
Progenity Receives Funding from Crohn’s & Colitis Foundation IBD Ventures
11 May 2021 //
GLOBENEWSWIRE
Progenity and Ionis Pharmaceuticals Enter into Agreement Antisense Therapies
06 Apr 2021 //
GLOBENEWSWIRE
